期刊文献+

利培酮长效注射剂在精神分裂症临床治疗中应用 被引量:1

Clinical application of long-acting risperidone injection in treating schizophrenia
暂未订购
导出
摘要 目的:介绍第二代抗精神病药物中第一个长效注射剂利培酮用于临床治疗精神分症的研究进展。资料来源:应用计算机检索Medline2003-01/2005-11期间与利培酮长效注射剂有关的文章,检索词为“RisperidoneLong-actingInjection”或“RisperdalConsta”。限定文章语言种类为English,研究对象为人类。资料选择:对资料进行初审,选择随机对照研究和临床研究作为纳入条件。排除综述、个案报道、经验总结、临床指南等文献。资料提炼:共收集符合条件的文献26篇,排除药代动力学研究文献3篇,类似文献4篇,选择符合本课题的要求的19篇文献进行综述。资料综合:利培酮长效注射剂是治疗精神分裂症和分裂情感性精神病安全有效的新型药物,不良反应少,可以由口服抗精神病药物或第一代抗精神病药物长效注射剂安全地换用利培酮长效注射剂治疗。老年患者同样安全有效,无种族差异。同时具有显著的药物经济学价值,可改善患者的生活质量。结论:利培酮长效注射剂是治疗精神分裂症和分裂情感性精神病安全有效的新型药物。 OBJECTIVE: To introduce the research development of the first long-acting injection in the second-generation antipsychotic" rlsperidone in treating schizophrenia, DATA SOURCES: A computer-based online search of Medline was undertaken to identify articles about the risperldone long-acting injection published in English from January 2003 to November 2005 by using the keywords of "Risperldone Long-acting Injection" or "Risperdal Consta", with human as the subjects. STUDY SELECTION: The data were preliminarily checked and the literatures about "clinical trial" and "randomized controlled trial" were ineluded, and those literatures such as review articles, case reports, academic summary and clinical guide were excluded. DATA EXTRACTION: Totally 26 literatures were collected. Excluding 3 pharmacoklnetic literatures and 4 repetitive literatures, 19 of them were accorded with the inclusive criteria. DATA SYNTHESIS: Risperidone long-acting injection is a reliable and effective new medicine in treating schizophrenia and schizoaffective psychosis with few adverse reactions. It can be used by replacing the oral taken antipsychotics or the first-generation antipsychotlcs long-actlng injection. Risperidone long-acting injection is also safe and effective for the elderly and without race distinction, It is a cost saving therapeutic option for patients with schizophrenia and can improve the quality of life of patients with schizophrenia. CONCLUSION: Risperidone long-acting injection provides a new and promising therapeutic option for the treatment of schizophrenia and schizoaffective disorder.
作者 陶建青
出处 《中国临床康复》 CSCD 北大核心 2006年第34期142-144,共3页 Chinese Journal of Clinical Rehabilitation
  • 相关文献

参考文献19

  • 1Kane JM,Eerdekens M,Lindenmayer JP,et al.Long-acting injectable risperidone:efficacy and safety of the first long-acting atypical antipsychotic.Am J Psychiatry 2003,160(6):1125-32
  • 2Fleischhacker WW,Eerdekens M,Karcher K,et al.Treatment of schizophrenia with long-acting injectable risperidone:a 12-month open-label trial of the first long-acting second-generation antipsychotic.J Clin Psychiatry 2003,64(10):1250-7
  • 3Lasser RA,Bossie CA,Gharabawi GM,et al.Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone:a 12-month open trial.Int J Neuropsychopharmacol 2005,8(3):427-38
  • 4Lasser RA,Bossie CA,Gharabawi GM,et al.Remission in schizophrenia:Results from a 1-year study of long-acting risperidone injection,Schizophr Res 2005,77(2-3):215-27
  • 5Lasser R,Bossie CA,Gharabawi G,et al.Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder.J Affect Disord 2004,83(2-3):263-75
  • 6Mohl A,Westlye K,Opjordsmoen S,et al.Long-acting risperidone in stable patients with schizoaffective disorder.J Psychopharmacol 2005,19(5 Suppl):22-31
  • 7Chue P,Eerdekens M,Augustyns I,et al.Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets.Eur Neuropsychopharmacol 2005,15(1):111-7
  • 8Lindenmayer JP,Eerdekens E,Berry SA,et al.Safety and efficacy of long-acting risperidone in schizophrenia:a 12-week,multicenter,open-label study in stable patients switched from typical and atypical oral antipsychotics.J Clin Psychiatry 2004,65(8):1084-9
  • 9van Os J,Bossie CA,Lasser RA.Improvements in stable patients with psychotic disorders switched from oral conventional antipsychotics therapy to longacting risperidone.Int Clin Psychopharmacol 2004,19(4):229-32
  • 10Turner M,Eerdekens E,Jacko M,et al.Long-acting injectable risperidone:safety and efficacy in stable patients switched from conventional depot antipsychotics.Int Clin Psychopharmacol 2004, 19(4):241-9

同被引文献8

  • 1田成华,司天梅,舒良.第一个长效非典型抗精神病药:注射用利培酮微球[J].中国新药与临床杂志,2004,23(10):723-725. 被引量:11
  • 2陈庆华,陈刚,唐海芸.利培酮长效注射剂的药动学特征和临床应用[J].中国新药杂志,2006,15(15):1235-1238. 被引量:8
  • 3Rrbinson D,Woebner MG,Alvir JM,et al.Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder[J].Arch Gen Psychiatry, 1999, 56 (3) : 241-247.
  • 4Weiden PJ,Kozma C, Grogg A,et al.Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia [J]. Psychiatric Services,2004,55(8):886- 891.
  • 5Gitlin M,Nuechterlein K,Subotnik KL, et al.Clinieal outcome following neuroleptie discontinuation in patients with remitted recent-onset schizophrenia [J].Am J Psychiatry,2001,158(11): 1835-1842.
  • 6Remington G,Deros E,Eerdekens M,et al. Treatment with long-acting risperidone injection reduces healthcare resource use[J].Int J Neuropsyehophatmacol,2002,5 (Suppl 1) : S 189.
  • 7Chue P,Eerdekens M,Augustyns I,et al.Efficacy and safety of long-acting risperidone microspheres and risperidone oral tables[J].Schizophr Res, 2002,53(Suppl 3) : S174-S175.
  • 8陈经余,阮士秀.齐拉西酮治疗女性精神分裂症患者的疗效和安全性研究[J].中国循证医学杂志,2007,7(10):761-764. 被引量:7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部